Press Releases about Silo Pharma Inc
FDA Expands Access to MDMA for Treatment of PTSD
May 18, 2022
Exposures
Product Safety
Silo Pharma Inc. (SILO) Spotlight: Ketamine
May 12, 2022
Silo Pharma Inc. (SILO) Spotlight: Ketamine
May 11, 2022
Exposures
COVID-19
Studies Find Link Between ADHD, Fibromyalgia
May 04, 2022
Research Highlights the High Economic Cost of PTSD
April 29, 2022
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Focusing on Largely Underserved Indications
April 27, 2022
Topics
Intellectual Property
Exposures
Intellectual Property
Silo Pharma Inc. (SILO) Is ‘One to Watch’
March 30, 2022
Why the North America Psychedelic Drugs Market is Expected to Grow With the Fastest CAGR for Next Several Years
June 08, 2021
Topics
Law Enforcement
Exposures
Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|